sulfinpyrazone has been researched along with Edema, Cardiac in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Edema, Cardiac: Abnormal fluid retention by the body due to impaired cardiac function or heart failure. It is usually characterized by increase in venous and capillary pressure, and swollen legs when standing. It is different from the generalized edema caused by renal dysfunction (NEPHROTIC SYNDROME).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häuselmann, HJ | 1 |
| Studer, H | 1 |
1 trial available for sulfinpyrazone and Edema, Cardiac
| Article | Year |
|---|---|
[Antinatriuretic effect of sulfinpyrazone].
Topics: Adult; Double-Blind Method; Edema, Cardiac; Humans; Male; Natriuresis; Sodium; Sulfinpyrazone | 1981 |